ICMR Launches Biomedical Technology Transfer Platform to Accelerate Healthcare Innovation

The initiative represents a significant milestone in India’s journey towards becoming a global leader in healthcare innovation, medical technology, and public health research.

In a major push towards strengthening India's biomedical innovation ecosystem, the Indian Council of Medical Research (ICMR), under the Ministry of Health and Family Welfare, successfully organised "Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect" at the Manekshaw Centre in New Delhi. The landmark event emerged as one of India's largest biomedical innovation and technology transfer facilitation platforms, aimed at transforming indigenous medical research into affordable healthcare solutions through strategic industry collaboration.

The initiative represents a significant milestone in India's journey towards becoming a global leader in healthcare innovation, medical technology, and public health research. Through the Medical Innovation Patent Mitra programme, ICMR seeks to bridge the long-standing gap between laboratory discoveries and large-scale public healthcare applications by enabling structured partnerships between scientists, startups, researchers, and industry leaders.

The event was inaugurated by Union Minister of State (Independent Charge) for Ayush and Minister of State for Health and Family Welfare, Shri Prataprao Ganpatrao Jadhav, in the presence of Prof. Gobardhan Das, Member of NITI Aayog, senior policymakers, scientists, healthcare innovators, and representatives from industry and research institutions.

Addressing the gathering, Shri Prataprao Jadhav described the initiative as a transformative step in linking scientific research with industrial capabilities. He emphasised that India is rapidly transitioning from being a consumer of healthcare technologies to becoming a major producer of affordable and innovative medical solutions for the world.

The Minister stated that the initiative aligns closely with the vision of "Viksit Bharat 2047" by strengthening India's healthcare infrastructure through indigenous innovation and self-reliance. He highlighted that collaborations between public research institutions and private industry are essential for ensuring that scientific breakthroughs reach patients quickly and effectively.

Prof. Gobardhan Das of NITI Aayog noted that India possesses the scientific expertise, innovation capacity, and entrepreneurial ecosystem needed to emerge as a global hub for health technologies. He said the Medical Innovation Patent Mitra initiative will play a crucial role in intellectual property protection, commercialization of research, and acceleration of technology transfer from laboratories to society.

ICMR Director General and Secretary of the Department of Health Research, Dr. Rajiv Bahl, said the initiative reflects ICMR's commitment to ensuring that advanced biomedical research benefits the public through impactful partnerships and scalable healthcare solutions. According to him, India's research ecosystem is entering a new phase where innovation, patents, commercialization, and accessibility are becoming interconnected pillars of healthcare development.

One of the most significant outcomes of the event was the transfer of 41 public health technologies developed by ICMR institutes and innovators to industry partners for further development, manufacturing, and commercialization. These technologies span critical healthcare sectors including diagnostics, vaccines, medical devices, and biomedical technologies aimed at addressing pressing public health challenges.

Among the key technologies transferred were glycoconjugate and recombinant vaccines designed for Typhoid and Paratyphoid prevention, along with advanced diagnostic platforms for diseases such as Tuberculosis, Japanese Encephalitis, and Mpox. These innovations are expected to strengthen India's disease surveillance, preventive healthcare, and diagnostic capabilities.

In a pioneering development, ICMR also facilitated the transfer of well-characterized biomaterials, including inactivated Kyasanur Forest Disease (KFD) and Chandipura viruses, to industry stakeholders. Experts believe this move will significantly enhance India's biomedical manufacturing and vaccine research ecosystem by enabling advanced research and faster product development.

The event additionally witnessed the release of two major knowledge resources — the "Indian Biomedical Patent Landscape Report" and the "Technology Compendium." These publications are expected to provide valuable insights into India's evolving biomedical intellectual property ecosystem, innovation trends, and emerging healthcare technologies.

Over 100 cutting-edge technologies developed by ICMR institutes, researchers, startups, and innovators were showcased during the programme. The technologies covered a broad range of areas including therapeutics, diagnostics, digital healthcare solutions, vaccines, and medical devices. The platform enabled direct interaction between innovators and industry leaders, creating opportunities for licensing, partnerships, commercialization, and investment.

Industry experts participating in the event highlighted that India's biomedical sector is witnessing rapid expansion due to increased investments in healthcare innovation, biotechnology, pharmaceutical research, and digital health infrastructure. Government initiatives promoting startup ecosystems, Make in India, and Atmanirbhar Bharat have also accelerated indigenous technology development in the healthcare sector.

The Medical Innovations Patent Mitra initiative is expected to become a long-term institutional mechanism for promoting innovation-led healthcare growth in India. By enabling stronger public-private partnerships, the programme aims to reduce dependence on imported medical technologies while enhancing accessibility, affordability, and quality of healthcare products.

Healthcare analysts believe such initiatives are crucial for positioning India as a global innovation hub capable of developing affordable technologies not only for domestic needs but also for emerging economies across the world. The emphasis on technology transfer and commercialization is also expected to encourage more researchers and startups to invest in translational medical research.

As India moves towards the vision of Viksit Bharat 2047, initiatives like ICMR's Innovators-to-Industry Connect are expected to play a defining role in building a resilient healthcare ecosystem driven by science, innovation, entrepreneurship, and global collaboration.